CDK9 Antikörper (AA 104-315)
-
- Target Alle CDK9 Antikörper anzeigen
- CDK9 (Cyclin-Dependent Kinase 9 (CDK9))
-
Bindungsspezifität
- AA 104-315
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CDK9 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunofluorescence (fixed cells) (IF/ICC)
- Aufreinigung
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
- Immunogen
- CDK9 (Asp104-Phe315)
- Top Product
- Discover our top product CDK9 Primärantikörper
-
anti-Cyclin-Dependent Kinase 9 (CDK9) antibody
CDK9 Reaktivität: Human WB, IHC, IP, IF, ChIP-seq Wirt: Kaninchen Monoclonal unconjugated
anti-Cyclin-Dependent Kinase 9 (CDK9) antibodyCDK9 Reaktivität: Human WB, ELISA, IHC Wirt: Maus Monoclonal 1B5A7 unconjugated
anti-Cyclin-Dependent Kinase 9 (CDK9) (AA 153-372) antibodyCDK9 Reaktivität: Human WB, IHC, IP, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase 9 (CDK9) (AA 271-372) antibodyCDK9 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 2D7 unconjugated
anti-Cyclin-Dependent Kinase 9 (CDK9) (Internal Region) antibodyCDK9 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase 9 (CDK9) (AA 153-372) antibodyCDK9 Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase 9 (CDK9) antibodyCDK9 Reaktivität: Human, Maus, Ratte IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase 9 (CDK9) (AA 104-315) antibodyCDK9 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase 9 (CDK9) (AA 153-372) antibodyCDK9 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Cyclin-Dependent Kinase 9 (CDK9) (AA 141-372) antibodyCDK9 Reaktivität: Human, Ratte WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 500 μg/mL
- Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4 °C for frequent use. Aliquot and store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
-
- Target
- CDK9 (Cyclin-Dependent Kinase 9 (CDK9))
- Andere Bezeichnung
- Cyclin Dependent Kinase 9 (CDK9 Produkte)
- Synonyme
- C-2k antikoerper, CDC2L4 antikoerper, CTK1 antikoerper, PITALRE antikoerper, TAK antikoerper, wu:fb22e09 antikoerper, wu:fc06c02 antikoerper, c-2k antikoerper, cdc2l4 antikoerper, cdk9 antikoerper, ctk1 antikoerper, pitalre antikoerper, tak antikoerper, CDK9 antikoerper, CG5179 antikoerper, Dmel\\CG5179 antikoerper, P-TEF antikoerper, P-TEFb antikoerper, PTefb antikoerper, cyclin dependent kinase 9 antikoerper, cyclin-dependent kinase 9 (CDC2-related kinase) antikoerper, cyclin-dependent kinase 9 L homeolog antikoerper, cyclin-dependent kinase 9 antikoerper, Cyclin-dependent kinase 9 antikoerper, cyclin-dependent kinase 9 S homeolog antikoerper, CDK9 antikoerper, cdk9 antikoerper, cdk9.L antikoerper, Cdk9 antikoerper, cdk9.S antikoerper
- Pathways
- Zellzyklus
-
